1-Herzog AG. Catamenial epilepsy: definition, prevalence pathophysiology and treatment. Seizure. 2008; 17(2):151-159.
2-Herzog AG. Catamenial epilepsy: Update on prevalence, pathophysiology and treatment from the findings of the NIH Progesterone Treatment Trial. Seizure. 2015; 28:18-25.
3- Kaboutari J, Zendehdel M, Habibian S, Azimi M, Shaker M, Karimi B. The antiepileptic effect of sodium valproate during different phases of the estrous cycle in PTZ-induced seizures in rats. J Physiol Biochem. 2012; 68(2):155-161.
4-Reddy DS. Neuroendocrine aspects of catamenial epilepsy. Horm behave. 2013; 63(2):254-266.
5-Verrotti A, D’Egidio C, Agostinelli S, Verrotti C, Pavone P. Diagnosis and management of catamenial seizures: a review. Int J women's health.2012; 4:535–541.
6- Dhir A. Curcumin in epilepsy disorders. Phytother Res. 2018;32(10):1865-1875.
7- Dehkordi FM, Kaboutari J, Zendehdel M, Javdani M. The Antinocicptive effect of Artemisinin on the inflammatory pain and role of GABAergic and opioidergic systems. Korean J Pain.2019; 32 (3): 160-167.
8-Li J, Casteels T, Frogne T, Ingvorsen C, Honoré C, Courtney M, et al. Artemisinin targets GABAA receptor signaling and impair α cell identity. Cell.2017; 168: 86-100.
9-Liu HK. Artemisinin GABA signaling and cell reprogramming: when an old drug meets modern medicine. Sci Bul.2017; 62: 386-87.
10-Sanjana K, Shyamjith M, Deepa B, Rao SN, Pai PG. Effect of artesunate on maximal electroshock and pentylenetetrazole-induced seizures in albino mice. Int J Green Pharm. 2012;6(1)63-66.
11-Xin W, Omkaram G, Chase MC, Doodipala SR. Estrous Cycle Regulation of Extrasynaptic δ-Containing GABAA Receptor-Mediated Tonic Inhibition and Limbic Epileptogenesis. J Pharmacol Exp Ther.2013; 346(1):146–160.
12-Reddy DS, Woodrad R. Ganaxolone: a prospective overview. Drugs fut.2004; 29: 227-242.
13-Reddy DS. The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res.2009; 85:1-30.
14-Borowicz K, Czuczwar S, Piskorska B, Banach M. Neuroprotective actions of neurosteroids. Front endocrinol.2011;2:50-60.
15-Xin HE, Lu H, Yang LU, Mengmeng DOU, et al. The Protective Effects of Artemisinin on Penicillin Sodium-Induced Epileptic Seizures in Mice. Lat Am J Pharm.2016; 35(4):1241-1247.
16-Mendell, AL, MacLusky NJ. Neurosteroid metabolites of testosterone and progesterone differentially inhibit ERK phosphorylation induced by amyloid β in SH-SY5Y cells and primary cortical neurons. Brain Res.2018; 1686: 83-93.
17-Joshi S, Kapur J. Neurosteroid regulation of GABAA receptors: a role in catamenial epilepsy. Brain Res.2019; 1703:31-40.
20- Johnston, Graham AR. Advantages of an antagonist: bicuculline and other GABA antagonists. Brit J Pharmacol.2013; 169 (2): 328–336.
18-Al-Dahan MI, Tehrani MHJ, Thalmann RH. Regulation of γ-aminobutyric acid B (GABAB) receptors in cerebral cortex during the estrous cycle. Brain Res.1994; 640: 33-39.
19-Al-Dahan MI, Thalman RH. Progesterone regulates gamma-aminobutyric acid B (GABAB) receptors in the neocortex of female rats. Brain Res.1996; 727: 40-48.
21-Zendehdel M, Kaboutari J, Ghadimi D, Hassanpour S. The antiepileptic effect of ghrelin during different phases of the estrous cycle in PTZ-induced seizures in rat. Int J Pept Res Ther.2014; 20(4): 511-517.
22-Zimmermann M (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain.1983; 16: 109-10.
